Regeneron says monoclonal antibodies prevent Covid-19 in study

Regeneron said Tuesday that its monoclonal antibody cocktail prevented Covid-19 in a clinical trial.

The news, issued via a press release, mirrored similar news from Eli Lilly last week that its monoclonal antibody prevented symptomatic Covid-19 infections in nursing homes.